Denne siden er tilgjengelig på flere språk
Select Language

CSAM Health fortsetter ekspansjonen på Børsen

Back

Oslo, 9. oktober 2020 – CSAM ble i dag tatt opp til handel på Merkur Market. – Gjennom børsnoteringen får vi tilgang til kapital for å fortsette vår sterke ekspansjon, kommenterer selskapet.

CSAM har spesialisert seg på e-helse-løsninger til sykehusene. I forbindelse med noteringen på Merkur Market hentet selskapet 825 millioner i en aksjeemisjon, der utstedelse av nye aksjer stod for 325 millioner kroner og nedsalg fra eksisterende eiere 500 millioner kroner. Emisjonen ble møtt med stor interesse, både fra norske og utenlandske investorer, og ble betydelig overtegnet, meldte selskapet

–  Vi er stolte og glade for den svært store interessen som CSAM har opplevet hos både nordiske og internasjonale kvalitetsinvestorer, sier Sverre Flatby, adm. direktør i CSAM.  

– Dagen i dag representerer en milepæl i CSAMs historie. Gjennom denne børsintroduksjonen bredder vi aksjonærbasen betydelig og får dermed tilgang til kapital for å fortsette vår sterke ekspansjon, sier Einar Bonnevie, finansdirektør i CSAM. 

CSAM har også lånt 300 millioner kroner gjennom et obligasjonslån, som planlegges notert på Børsen. 

CSAM admitted to trading on Merkur Market

Foto: Thomas Brun / NTB

Om CSAM Health Group  CSAM is the leading provider of niche eHealth solutions in the Nordics. The company’s leading product portfolio includes innovative niche solutions in connected healthcare, medical imaging, women and children's health, emergency and acute care, medication management, and laboratory information management systems, that enable healthcare providers to access relevant clinical information at the point of care. CSAM is headquartered in Oslo, and has operations in Norway, Sweden, Finland, Denmark, and the UK, as well as a wholly owned software engineering subsidiary in the Philippines. www.csamhealth.com/about-csam/

 

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €7.1 trillion in market capitalisation as of end March 2024, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2024, Euronext N.V. - All rights reserved.